Association of a Leukemic Stem Cell Gene Expression Signature With Clinical Outcomes in Acute Myeloid Leukemia
Top Cited Papers
Open Access
- 22 December 2010
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 304 (24), 2706-2715
- https://doi.org/10.1001/jama.2010.1862
Abstract
Acute myeloid leukemia (AML) is an aggressive malignancy of the bone marrow characterized by accumulation of early myeloid blood cells that fail to mature and differentiate. The course of the disease is marked by poor prognosis, frequent relapse, and high disease–related mortality.1,2 Recent clinical investigation has focused on the identification of prognostic subgroups in adult AML with the goal of guiding patients into risk-adapted therapies. Such investigation determined that cytogenetic abnormalities are prognostic, some favorable and others unfavorable,3,4 yet up to 50% of patients have normal karyotype AML with a wide range of clinical outcomes. In these patients, the presence of specific molecular mutations can provide prognostic information, including internal tandem duplications within the FLT3 gene, partial tandem duplication of the MLL gene, mislocalizing mutations of the NPM1 gene, mutations in the CEBPA and RAS genes, and increased expression of the BAALC and ERG genes.5,6 However, these parameters and others such as patient age are only partially successful at capturing risk of relapse and patient outcomes following treatment.Keywords
This publication has 55 references indexed in Scilit:
- Regulating the leukaemia stem cellBest Practice & Research Clinical Haematology, 2009
- Proteomic and Genetic Approaches Identify Syk as an AML TargetCancer Cell, 2009
- Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia GenomeNew England Journal of Medicine, 2009
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem CellsCell, 2009
- Module Map of Stem Cell Genes Guides Creation of Epithelial Cancer Stem CellsCell Stem Cell, 2008
- A Chromatin Landmark and Transcription Initiation at Most Promoters in Human CellsCell, 2007
- Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9Nature, 2006
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerNew England Journal of Medicine, 2004
- PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetesNature Genetics, 2003
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997